REQUEST A DEMO
Total
USD $0.00
Search more companies

Aba Medica Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores
Full name: Aba Medica Sp. z o.o. Profile Updated: April 14, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Aba Medica Sp. z o.o. is an enterprise located in Poland, with the main office in Poznan. The company operates in the Pharmacies and Drug Stores sector. It was incorporated on March 11, 2021. From the latest financial highlights, Aba Medica Sp. z o.o. reported a net sales revenue drop of 2.84% in 2022. Its’ total assets recorded a growth of 16.7%. The net profit margin of Aba Medica Sp. z o.o. increased by 4.45% in 2022.

Headquarters
Ul. Promienista 25
Poznan; Wielkopolskie; Postal Code: 60-288

Contact Details: Purchase the Aba Medica Sp. z o.o. report to view the information.

Website: http://www.abamedica.pl

Basic Information
Outstanding Shares:
Purchase the Aba Medica Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Aba Medica Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Aba Medica Sp. z o.o. report to view the information.
Incorporation Date:
March 11, 2021
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
66.67%
Purchase this report to view the information.
24%
Subsidiaries
Cito Max Sp. z o.o.
99%
Company Performance
Financial values in the chart are available after Aba Medica Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-2.84%
Total operating revenue
-2.82%
Operating profit (EBIT)
-369.45%
EBITDA
-320.81%
Net Profit (Loss) for the Period
375.33%
Total assets
16.7%
Total equity
5.35%
Operating Profit Margin (ROS)
-1.09%
Net Profit Margin
4.45%
Return on Equity (ROE)
16.16%
Quick Ratio
-0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?